Form 4/A for OGN Organon & Co.
Accepted 2026-01-16 00:00:00 ET · period of report 2025-11-07 · accession 0001628280-26-002406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-01-16 | 2025-11-07 | OGN | Drinane Juliana Papa | Interim Head of Mfg, Supply | F - Tax | $6.71 | -1,242 | 17.2K | -7% | -$8,334 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-07 | F | D | 1,242 | $6.71 | 17,174.70 | D | — | — | (F1) On November 12, 2025, the reporting person filed a Form 4 which inadvertently reported that she acquired (A) 1,242 shares of Organon & Co. (Organon) common stock due to the sale of shares to satisfy a tax liability related to the acquisition of other shares of Organon common stock (code F), where in fact this number of shares should have been reported as a transaction resulting in her disposal (D) of such shares to satisfy the tax liability. As a result, the total amount of securities beneficially owned by the reporting person following such sale transaction on November 7, 2025, is now correctly reported on this Form 4 in column 5 as 17,174.703. |